120 related articles for article (PubMed ID: 26914517)
1. Abrus agglutinin is a potent anti-proliferative and anti-angiogenic agent in human breast cancer.
Bhutia SK; Behera B; Nandini Das D; Mukhopadhyay S; Sinha N; Panda PK; Naik PP; Patra SK; Mandal M; Sarkar S; Menezes ME; Talukdar S; Maiti TK; Das SK; Sarkar D; Fisher PB
Int J Cancer; 2016 Jul; 139(2):457-66. PubMed ID: 26914517
[TBL] [Abstract][Full Text] [Related]
2. Abrus agglutinin promotes irreparable DNA damage by triggering ROS generation followed by ATM-p73 mediated apoptosis in oral squamous cell carcinoma.
Sinha N; Panda PK; Naik PP; Das DN; Mukhopadhyay S; Maiti TK; Shanmugam MK; Chinnathambi A; Zayed ME; Alharbi SA; Sethi G; Agarwal R; Bhutia SK
Mol Carcinog; 2017 Nov; 56(11):2400-2413. PubMed ID: 28543759
[TBL] [Abstract][Full Text] [Related]
3. Abrus agglutinin inhibits oral carcinogenesis through inactivation of NRF2 signaling pathway.
Panigrahi DP; Bhol CS; R N; Nagini S; Patil S; Maiti TK; Bhutia SK
Int J Biol Macromol; 2020 Jul; 155():1123-1132. PubMed ID: 31715238
[TBL] [Abstract][Full Text] [Related]
4. Abrus precatorius agglutinin-derived peptides induce ROS-dependent mitochondrial apoptosis through JNK and Akt/P38/P53 pathways in HeLa cells.
Behera B; Mishra D; Roy B; Devi KS; Narayan R; Das J; Ghosh SK; Maiti TK
Chem Biol Interact; 2014 Oct; 222():97-105. PubMed ID: 25305377
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rd regulates the Akt/mTOR/p70S6K signaling cascade and suppresses angiogenesis and breast tumor growth.
Zhang E; Shi H; Yang L; Wu X; Wang Z
Oncol Rep; 2017 Jul; 38(1):359-367. PubMed ID: 28534996
[TBL] [Abstract][Full Text] [Related]
6. Abrus Agglutinin, a type II ribosome inactivating protein inhibits Akt/PH domain to induce endoplasmic reticulum stress mediated autophagy-dependent cell death.
Panda PK; Behera B; Meher BR; Das DN; Mukhopadhyay S; Sinha N; Naik PP; Roy B; Das J; Paul S; Maiti TK; Agarwal R; Bhutia SK
Mol Carcinog; 2017 Feb; 56(2):389-401. PubMed ID: 27182794
[TBL] [Abstract][Full Text] [Related]
7. p73 induction by Abrus agglutinin facilitates Snail ubiquitination to inhibit epithelial to mesenchymal transition in oral cancer.
Sinha N; Meher BR; Naik PP; Panda PK; Mukhapadhyay S; Maiti TK; Bhutia SK
Phytomedicine; 2019 Mar; 55():179-190. PubMed ID: 30668428
[TBL] [Abstract][Full Text] [Related]
8. Abrus agglutinin suppresses human hepatocellular carcinoma in vitro and in vivo by inducing caspase-mediated cell death.
Mukhopadhyay S; Panda PK; Das DN; Sinha N; Behera B; Maiti TK; Bhutia SK
Acta Pharmacol Sin; 2014 Jun; 35(6):814-24. PubMed ID: 24793310
[TBL] [Abstract][Full Text] [Related]
9. Abrus agglutinin targets cancer stem-like cells by eliminating self-renewal capacity accompanied with apoptosis in oral squamous cell carcinoma.
Sinha N; Panda PK; Naik PP; Maiti TK; Bhutia SK
Tumour Biol; 2017 May; 39(5):1010428317701634. PubMed ID: 28459216
[TBL] [Abstract][Full Text] [Related]
10. Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo.
Ananda Sadagopan SK; Mohebali N; Looi CY; Hasanpourghadi M; Pandurangan AK; Arya A; Karimian H; Mustafa MR
J Exp Clin Cancer Res; 2015 Dec; 34():147. PubMed ID: 26643256
[TBL] [Abstract][Full Text] [Related]
11. Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis.
Yang GW; Jiang JS; Lu WQ
Int J Mol Sci; 2015 Oct; 16(10):24011-31. PubMed ID: 26473837
[TBL] [Abstract][Full Text] [Related]
12. PUMA dependent mitophagy by Abrus agglutinin contributes to apoptosis through ceramide generation.
Panda PK; Naik PP; Meher BR; Das DN; Mukhopadhyay S; Praharaj PP; Maiti TK; Bhutia SK
Biochim Biophys Acta Mol Cell Res; 2018 Mar; 1865(3):480-495. PubMed ID: 29229477
[TBL] [Abstract][Full Text] [Related]
13. Prokaryotically and eukaryotically expressed interleukin-24 induces breast cancer growth suppression via activation of apoptosis and inhibition of tumor angiogenesis.
Wei S; Cao H; Zhou X; Wu H; Yang J
Mol Med Rep; 2015 May; 11(5):3673-81. PubMed ID: 25544477
[TBL] [Abstract][Full Text] [Related]
14. Deacetylation of LAMP1 drives lipophagy-dependent generation of free fatty acids by Abrus agglutinin to promote senescence in prostate cancer.
Panda PK; Patra S; Naik PP; Praharaj PP; Mukhopadhyay S; Meher BR; Gupta PK; Verma RS; Maiti TK; Bhutia SK
J Cell Physiol; 2020 Mar; 235(3):2776-2791. PubMed ID: 31544977
[TBL] [Abstract][Full Text] [Related]
15. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
[TBL] [Abstract][Full Text] [Related]
16. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
Fan Y; Peng A; He S; Shao X; Nie C; Chen L
J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
[TBL] [Abstract][Full Text] [Related]
17. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
[TBL] [Abstract][Full Text] [Related]
18. Dual function of RGD-modified VEGI-192 for breast cancer treatment.
Wu J; Jiang Y; Yang W; He Z; Meng S; Zhang Q; Lin M; Zhang H; Li W; Yang Y; Jia Y; Qian L; Lu D; Cai W; Luo G; Wang Y; Zhu X; Li M
Bioconjug Chem; 2012 Apr; 23(4):796-804. PubMed ID: 22455451
[TBL] [Abstract][Full Text] [Related]
19. Cacalol, a natural sesquiterpene, induces apoptosis in breast cancer cells by modulating Akt-SREBP-FAS signaling pathway.
Liu W; Furuta E; Shindo K; Watabe M; Xing F; Pandey PR; Okuda H; Pai SK; Murphy LL; Cao D; Mo YY; Kobayashi A; Iiizumi M; Fukuda K; Xia B; Watabe K
Breast Cancer Res Treat; 2011 Jul; 128(1):57-68. PubMed ID: 20665104
[TBL] [Abstract][Full Text] [Related]
20. Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model.
Kim E; Tunset HM; Cebulla J; Vettukattil R; Helgesen H; Feuerherm AJ; Engebråten O; Mælandsmo GM; Johansen B; Moestue SA
BMC Cancer; 2016 Mar; 16():191. PubMed ID: 26951085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
